|
110 Companies |
|
139 Products |
|
139 Products |
|
95 Mechanisms of Action |
|
2 Trials |
|
919 News |
|
| «12...78910111213141516171819 |
- Ozespa (briakinumab) / AbbVie
Trial withdrawal: Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates. (clinicaltrials.gov) - Oct 19, 2011
P1, N=12, Withdrawn, Sponsor: Abbott
Terminated --> Withdrawn
- ||| Remicade (infliximab) / Merck (MSD), Mitsubishi Tanabe, J&J
Trial completion: REMission: Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840) (clinicaltrials.gov) - Oct 12, 2011
P=N/A, N=4485, Completed, Sponsor: Merck Sharp & Dohme Corp.
Terminated --> Withdrawn Active, not recruiting --> Completed
- bexarotene/betamethasone dipropionate (LAS 41004) / Almirall
New P2 trial: Efficacy and Tolerability of LAS41004 Formulations in a Non-occlusive Psoriasis Plaque Test (clinicaltrials.gov) - Oct 3, 2011
P2, N=22, Completed, Sponsor: Almirall, S.A.
- Trial termination: Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions (clinicaltrials.gov) - Oct 2, 2011
P1/2, N=50, Terminated, Sponsor: University of Michigan
Active, not recruiting --> Completed Active, not recruiting --> Terminated; Slow enrollment
- | New P1/2 trial: Study in Patients With Mild to Moderate Psoriasis (clinicaltrials.gov) - Oct 2, 2011
P1/2, N=47, Completed, Sponsor: Alimentary Health Ltd
- |||| Cosentyx (secukinumab) / Novartis
Trial completion: AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis (clinicaltrials.gov) - Sep 29, 2011
P2, N=404, Completed, Sponsor: Novartis Pharmaceuticals
Active, not recruiting --> Terminated; Slow enrollment Active, not recruiting --> Completed
- | Trial completion: Efficacy Study of TEPSO® Socks in Improving Palmoplantar Psoriasis (clinicaltrials.gov) - Sep 25, 2011
P2, N=20, Completed, Sponsor: Lenzi Egisto S.P.A.
Active, not recruiting --> Completed Recruiting --> Completed
- Trial completion, Review: Systematic Review And Meta-Analysis Of Psoriasis Treatments. (clinicaltrials.gov) - Sep 19, 2011
P=N/A, N=0, Completed, Sponsor: Pfizer
Recruiting --> Completed Active, not recruiting --> Completed
- |||| ulodesine (BCX4208) / BioCryst
Trial completion: A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis. (clinicaltrials.gov) - Sep 18, 2011
P2, N=66, Completed, Sponsor: Hoffmann-La Roche
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment closed: Prevalence of Sleep Disturbances in Psoriasis (clinicaltrials.gov) - Sep 12, 2011
P=N/A, N=80, Active, not recruiting, Sponsor: Wake Forest School of Medicine
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- |||| LEO 22811 / LEO Pharma
Trial completion: A Proof of Concept Study Comparing Three Doses of an Oral Solution of LEO 22811 With a Placebo Oral Solution for the Treatment of Psoriasis Vulgaris (clinicaltrials.gov) - Sep 11, 2011
P2, N=63, Completed, Sponsor: LEO Pharma
Recruiting --> Active, not recruiting Recruiting --> Completed
- Enbrel (etanercept) / Pfizer, Amgen
New P4 trial: Post Marketing Surveillance To Observe Safety And Efficacy Of Enbrel In Pediatric Patients With Psoriasis (clinicaltrials.gov) - Sep 8, 2011
P4, N=0, Withdrawn, Sponsor: Pfizer
- | triamcinolone acetonide topical / Generic mfg.
New P4 trial: DIPSO: Steroids Added to Dithranol and Narrow Band UVB(Ultraviolet B) (UVBnb) in Psoriasis (clinicaltrials.gov) - Sep 5, 2011
P4, N=88, Recruiting, Sponsor: University of Zurich
- Remicade (infliximab) / Merck (MSD), Mitsubishi Tanabe, J&J
Enrollment change: Five-Year Observation of Remicade Treatment for Plaque Psoriasis in Austria (Study P04900) (clinicaltrials.gov) - Aug 31, 2011
P=N/A, N=26, Completed, Sponsor: Merck Sharp & Dohme Corp.
Recruiting --> Completed N=50 --> 26
- | Humira (adalimumab) / AbbVie
Trial completion: Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea (clinicaltrials.gov) - Aug 31, 2011
P4, N=20, Completed, Sponsor: Innovaderm Research Inc.
N=50 --> 26 Active, not recruiting --> Completed
- |||||||||| Dovonex (calcipotriol) / LEO Pharma, Novartis
New P3 trial: LEO 90105 Ointment in Japanese Subjects With Psoriasis (clinicaltrials.gov) - Aug 22, 2011
P3, N=677, Completed, Sponsor: LEO Pharma
- ||||||| Trial completion: The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body Psoriasis (clinicaltrials.gov) - Aug 11, 2011
P3, N=363, Completed, Sponsor: Stiefel, a GSK Company
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||||| calcipotriol/betamethasone dipropionate / Generic mfg.
Trial completion: LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs) (clinicaltrials.gov) - Aug 11, 2011
P3, N=1152, Completed, Sponsor: LEO Pharma
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Humira (adalimumab) / Eisai, AbbVie
Trial completion: Primary UVB-311nm and Adalimumab in Psoriasis Patients (clinicaltrials.gov) - Aug 8, 2011
P=N/A, N=4, Completed, Sponsor: Medical University of Graz
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| Cosentyx (secukinumab) / Novartis
New P3 trial: STATURE: Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis (clinicaltrials.gov) - Aug 7, 2011
P3, N=140, Completed, Sponsor: Novartis Pharmaceuticals
- ||||||| cyclosporin A microemulsion / Generic mfg.
Trial completion: Efficacy and Safety of Cyclosporine A Microemulsion in Maintenance Patients With Chronic Plaque Psoriasis (clinicaltrials.gov) - Aug 7, 2011
P3, N=243, Completed, Sponsor: Novartis Pharmaceuticals
Active, not recruiting --> Completed Recruiting --> Completed